Unboxing Biotech

Unboxing Biotech is a life sciences-focused media, research, and investor communications business rather than a therapeutic drug developer. The company provides biotech equity research, educational video and podcast content, executive consulting, digital marketing, and investor relations support for biotechnology and healthcare companies. Its offering is centered on helping life sciences companies communicate complex science and clinical developments to investors through written analysis and media content. The business appears to be led by John D. Vandermosten, CFA, and highlights coverage across oncology, gene and cell therapy, neurodegenerative disease, rare disease, regenerative medicine, and precision medicine. Based on available public information, Unboxing Biotech does not appear to maintain an internal therapeutic pipeline.